Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T14:56:35.531Z.
Calculation as of: 2026-10-06T14:56:35.531Z.
Quote observation: 2026-10-06T14:10:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 015f4768d679608bc4b6bcfba81ca244afda57a14a617ca6285ea64adc9468bc
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Drugs Made In America Acquisition Corp. Ordinary Shares
Market Cap
$263.65M
Price/FCF Ratio
N/A
Market Cap
$262.55M
Price/FCF Ratio
N/A
Market Cap
$261.73M
Price/FCF Ratio
N/A
Market Cap
$261.39M
Price/FCF Ratio
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO |
|---|---|---|
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) | $263.65M | N/A |
| Oaktree Acquisition Corp. II (OACC)vs › | $264.39M | N/A |
| Cantor Equity Partners V, Inc. Class A Ordinary Shares (CEPV)vs › | $262.55M | N/A |
| Art Technology Acquisition Corp. (ARTC)vs › | $261.77M | N/A |
| AMR Resources Acquisition Corp Class A Ordinary Shares (AMAC)vs › | $261.73M | N/A |
| Mountain Lake Acquisition Corp. II Class A Ordinary Shares (MLAA)vs › | $261.39M | N/A |
| Thunder Bridge Capital Partners V L (TBCVU)vs › | $266.05M | N/A |
| GigCapital8 Corp. (GIW)vs › | $261.19M | N/A |
| FACT II Acquisition Corp (FACT)vs › | $260.73M | N/A |
| Hawthorn Bancshares, Inc. (HWBK)vs › | $267.33M | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
